BALAMINES.BOBALAMINES.BOBSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank79
5Y CAGR+2.5%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

5Y CAGR
+2.5%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202510.58%
2024-41.74%
2023117.02%
2022-40.65%
202175.55%
20209.35%
2019-0.65%
2018-11.43%
201769.38%
20160.00%